David B. Roberts - Sep 9, 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
President and Director, Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Sep 9, 2021
Transactions value $
$0
Form type
4
Date filed
9/13/2021, 04:09 PM
Previous filing
Jul 30, 2021
Next filing
Nov 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Award $0 +1 +4.55% $0.00 23 Sep 9, 2021 Common Stock 1 Direct F1
transaction LMAT Dividend Equivalent Rights Award $0 +3 +6.67% $0.00 48 Sep 9, 2021 Common Stock 3 Direct F2
transaction LMAT Dividend Equivalent Rights Award $0 +2 +8.7% $0.00 25 Sep 9, 2021 Common Stock 2 Direct F3
transaction LMAT Dividend Equivalent Rights Award $0 +3 +50% $0.00 9 Sep 9, 2021 Common Stock 3 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.